©The Author(s) 2026.
World J Pharmacol. Jan 19, 2026; 15(1): 113080
Published online Jan 19, 2026. doi: 10.5497/wjp.v15.i1.113080
Published online Jan 19, 2026. doi: 10.5497/wjp.v15.i1.113080
Figure 2 Physiological effects of glucagon-like peptide-1.
The physiological effects of glucagon-like peptide-1 (GLP-1) are extensive. GLP-1: Glucagon-like peptide-1; POMC: Pro-opiomelanocortin; CART: Cocaine amphetamine regulated transcript; NPY: Neuropeptide Y; AgRP: Agouti-related peptide.
- Citation: Deng CX, Chen ZM, Tang YX, Xi ZX, Wang SY, Wu HY, Xu B, Xu TC. Mazdutide: An emerging glucagon/GCG-like peptide-1 dual receptor agonist for obesity—a comparison of therapeutic effects and potential side effects with GCG-like peptide-1 inhibitors. World J Pharmacol 2026; 15(1): 113080
- URL: https://www.wjgnet.com/2220-3192/full/v15/i1/113080.htm
- DOI: https://dx.doi.org/10.5497/wjp.v15.i1.113080